Cargando…

Multiple Primary Melanoma in a CHEK2 Mutation Carrier

Detalles Bibliográficos
Autores principales:	Álvarez-Salafranca, Marcial, Felipo-Berlanga, Francesc, García-García, Mar, Aldea-Manrique, Beatriz, Ara, Mariano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412052/ https://www.ncbi.nlm.nih.gov/pubmed/37557106 http://dx.doi.org/10.5826/dpc.1303a194

Ejemplares similares

Hidden clear cell acanthoma with uncommon dermoscopic findings()()
por: Álvarez-Salafranca, Marcial, et al.
Publicado: (2021)

Generalized granuloma annulare after pneumococcal vaccination()()
por: García-Gil, Miguel Fernando, et al.
Publicado: (2021)

Selenium and cancer risk in CHEK2 mutation carriers
por: Gupta, Satish, et al.
Publicado: (2012)

Neutrophilic dermatosis of the dorsal hands related to cocaine abuse()()
por: Álvarez-Salafranca, Marcial, et al.
Publicado: (2021)

Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
por: Toss, Angela, et al.
Publicado: (2021)

Cutaneous Red Cords and Plaques in a Polymedicated Patient
por: Villagrasa-Boli, Pablo, et al.
Publicado: (2023)

The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
por: Mandelker, Diana, et al.
Publicado: (2019)

Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers
por: Kriege, Mieke, et al.
Publicado: (2015)

The Prevalence of CHEK1 and CHEK2 Mutations in Prostate Cancer: a Retrospective Cohort Study
por: Alorjani, Mohammed, et al.
Publicado: (2023)

Cancer risks in first-degree relatives of CHEK2 mutation carriers: effects of mutation type and cancer site in proband
por: Gronwald, J, et al.
Publicado: (2009)

CHEK2 Mutation in Patient with Multiple Endocrine Glands Tumors. Case Report
por: Szeliga, Anna, et al.
Publicado: (2020)

Risk for contralateral breast cancer among carriers of the CHEK2(*)1100delC mutation in the WECARE Study
por: Mellemkjær, L, et al.
Publicado: (2008)

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
por: Muranen, Taru A, et al.
Publicado: (2011)

Population Screening of CHEK2 Mutations in Poland
por: Cybulski, Cezary, et al.
Publicado: (2006)

CHEK2 mutations in pediatric brain tumors
por: Tlais, Dana, et al.
Publicado: (2023)

The CHEK 2 GENE mutations and the risk of Gastric cancer
por: Teodorczyk, Urszula, et al.
Publicado: (2012)

Prevalence of the CHEK2 R95* germline mutation
por: Knappskog, Stian, et al.
Publicado: (2016)

Current perspectives on CHEK2 mutations in breast cancer
por: Apostolou, Panagiotis, et al.
Publicado: (2017)

A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland
por: Bąk, Aneta, et al.
Publicado: (2014)

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2021)

The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012)

CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012)

Clinical relevance of CHEK2 and NBN mutations in the macedonian population
por: Kostovska, I Maleva, et al.
Publicado: (2015)

Survival of bladder or renal cancer in patients with CHEK2 mutations
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2021)

CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?
por: Koen, Kortbeek, et al.
Publicado: (2022)

Recurrent Acromegaly in a Patient With a CHEK2 Mutation
por: Perosevic, Milica, et al.
Publicado: (2021)

Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures
por: Ow, Ghim Siong, et al.
Publicado: (2014)

CHEK2 (∗)1100delC Mutation and Risk of Prostate Cancer
por: Hale, Victoria, et al.
Publicado: (2014)

Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
por: Xie, Changqing, et al.
Publicado: (2018)

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile
por: Smid, Marcel, et al.
Publicado: (2023)

CHEK2 1100 delC mutation in Russian ovarian cancer patients
por: Krylova, Nadezhda Yu, et al.
Publicado: (2007)

Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
por: Massink, Maarten P. G., et al.
Publicado: (2015)

Germline mutation of CHEK2 in neurofibromatosis 1 and 2: Two case reports
por: Li, Qiang, et al.
Publicado: (2018)

An association study between CHEK2 gene mutations and susceptibility to breast cancer
por: Jalilvand, Manizheh, et al.
Publicado: (2017)

Maternal heterozygous mutation in CHEK1 leads to mitotic arrest in human zygotes
por: Chen, Beili, et al.
Publicado: (2021)

SAT573 Incidental Discovery Of CHEK2 Mutation With Papillary Thyroid Cancer
por: Thelmo, Franklin L, et al.
Publicado: (2023)

Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2
por: Bychkovsky, Brittany L., et al.
Publicado: (2022)

The CHEK2(*)1100delC mutation has no major contribution in oesophageal carcinogenesis
por: Koppert, L B, et al.
Publicado: (2004)

The First Case Report of a Patient With Oligodendroglioma Harboring CHEK2 Germline Mutation
por: Li, Xueen, et al.
Publicado: (2022)

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor
por: Brandão, Andreia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7fjq8v32difod4dhe8amchvtbh